Serum Levels of Glycoproteins are Elevated in Patients with Ovarian Cancer
- PMID: 24966484
- PMCID: PMC4062676
- DOI: 10.1007/s12291-013-0380-6
Serum Levels of Glycoproteins are Elevated in Patients with Ovarian Cancer
Abstract
Identification of reliable biomarkers for detection and staging of cancer and monitoring the outcome of anticancer therapy has been considered to be of high importance. We aimed to estimate the levels of serum glycoproteins, protein bound-hexose, protein bound hexosamine, protein bound fucose, protein bound sialic acid and protein bound carbohydrate in 32 ovarian cancer patients and compared them with the levels that found in 25 normal subjects. As compared to the normal subjects, all the four fractions of glycoproteins level were significantly elevated in ovarian cancer patients (p < 0.05). Chemotherapy in these patients significantly decreased the levels of serum glycoproteins (p < 0.05). Thus, high levels of serum glycoproteins in ovarian cancer patients could be due to abnormal protein glycosylation indicating malignant transformation of the cells.
Keywords: Glycoproteins; Ovarian cancer; Protein bound carbohydrate; Protein bound hexosamine; Serum hexose; Sialic acid.
Figures
References
-
- Bhatt AN, Mathur R, Farooque A, Verma A, Dwarakanath BS. Cancer biomarkers—Current perspectives. Indian J Med Res. 2010;132:129–149. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials